Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Maximize Value

Developing strategies to accelerate the shift from volume to value

Despite a slowdown in deal making, pharmaceuticals and healthtech continue to get attention from investors.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, HLS Private Capital, Oliver Wyman
Consultant, HLS Private Capital, Oliver Wyman

The current economic climate opens the door for investors and innovators to rethink partnerships and ways to access capital.

Partner, Health and Life Sciences, Oliver Wyman
Senior Editor, Health and Life Sciences, Oliver Wyman

The FED is experiencing criticism for being too slow to tighten financial conditions, and failing to recognize inflation. Executives from Mercer discuss the potential recession and whether it will it cause a significant impact.

Head of Asset Allocation, International Ex-Pacific, Mercer
Chief Investment Officer, Mercer

Health systems are seeking payment increases to shore up finances that have been hit hard by COVID-19 and rising labor costs. We identified key considerations for insurers as they enter these negotiations.

Partner, Health Services, Oliver Wyman

Healthcare organizations need to think about their partnerships — whether with private equity or other types of entities — through a strategic lens.

Operating Partner, Welsh, Carson, Anderson, and Stowe
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Pharmaceutical giants are shedding business units with an eye toward focusing on their innovative pharma operations and targeted therapeutic areas.

Head of UK and Ireland Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insurance markets showed great resiliency during the past 18 months as employment numbers fluctuated. Looking ahead, multiple legislative, regulatory, and market moves may cause shifts in the payer enrollment mix.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting
Senior Manager, Oliver Wyman Actuarial Consulting
Associate, Oliver Wyman

Impact of Extending the American Rescue Plan Act Premium Tax Credits Beyond 2022

Oliver Wyman analysis —conducted for the White House—highlights how the ARPA will make health insurance more affordable for millions of Americans.

Partner, Oliver Wyman Actuarial Consulting
Senior Manager, Oliver Wyman Actuarial Consulting

Out-of-Industry Lessons for Healthcare Leaders

Healthcare leaders have much to learn from the retail and aviation industries in their journey to transparency.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Retail and CPG, Oliver Wyman
Partner, Consumer and Industrials, Oliver Wyman

We're entering the Great Unknown regarding health insurance enrollment mix.

Partner, Health and Life Sciences, Oliver Wyman
Senior Manager, Oliver Wyman Actuarial Consulting
Partner, Oliver Wyman Actuarial Consulting
Associate, Oliver Wyman

Insights in your inbox

Subscribe